Paulson & Co’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-210,500
Closed -$9.74M 65
2017
Q2
$9.74M Sell
210,500
-21,300
-9% -$986K 0.13% 59
2017
Q1
$8.19M Buy
231,800
+129,800
+127% +$4.58M 0.11% 57
2016
Q4
$1.28M Hold
102,000
0.02% 80
2016
Q3
$1.41M Hold
102,000
0.02% 84
2016
Q2
$1.01M Hold
102,000
0.01% 74
2016
Q1
$1.73M Buy
102,000
+79,500
+353% +$1.34M 0.01% 77
2015
Q4
$501K Buy
+22,500
New +$501K ﹤0.01% 73